Name: How Portland could be key to breakthroughs in cancer research | The Story | Sept. 12, 2024
Uploaded: 2024-09-13T02:03:54Z
Channel: TEGNA

Kurator

For Seller Marketplace

Request License

> Media Pool

> How Portland could be key to breakthroughs in cancer research | The Story | Sept. 12, 2024

How Portland could be key to breakthroughs in cancer research | The Story | Sept. 12, 2024

Clip ID 2432423

Clearance

Add to

By Request

By Request assets are not available for immediate purchase.

This content has not been pre-checked for copyright.

Per clip rates are for 20 seconds of final usage. If you are using more then 20 seconds or need a different file format or have questions about clearances contact us

Description

Sept. 12 on The Story: In the early 1990s, Dr. Brian Druker was a medical researcher recruited by OHSU to head a lab focused on targeted therapies for cancers. His discovery of a treatment for a specific type of leukemia was developed into the drug Gleevec, an important development in targeted cancer treatment. Now he heads OHSU's Knight Cancer Institute, a top research center for multiple advancements in cancer treatments. We spoke to Druker to find out what's on the horizon in this vital field, and found out how an aspect of the product that Elizabeth Holmes and Theranos fraudulently marketed, blood tests for cancer, may soon be a reality that will revolutionize cancer detection. Watch more The Story videos: http://bit.ly/watchTheStory Follow The Story on Twitter: https://twitter.com/TheStoryKGW Follow The Story on Instagram: https://instagram.com/thestorykgw

Station

KGW

Keywords

the story kgw kgw the story the story pat dooris Brian Druker Gleevac imatinib OHSU Knight Cancer Institute cancer research cancer blood test targeted cancer drug

Add to Review Link

Add to Review Link